Table 2.
Clinical Characteristics of study participants (N = 211)
| Characteristic | Frequency | Percentage |
|---|---|---|
| Substance use in the past 3 months (n = 204) | ||
| No | 190 | 93.4 |
| Yes | 14 | 6.6 |
| Type of substance used (n = 14) | ||
| Tobacco | 6 | 42.9 |
| Alcoholic beverage | 8 | 57.1 |
| Frequency of substance use (n = 14) | ||
| Once/twice | 10 | 71.4 |
| Monthly | 4 | 28.6 |
| BDI II Scorea | ||
| Median = 1 (IQR: 0,4) | ||
| Age at diagnosis of HIV (n = 202) | ||
| < 10 years | 164 | 81.2 |
| ≥ 10 years | 38 | 18.8 |
| Median = 11 years (IQR: 9,12) | ||
| WHO HIV clinical stage | ||
| Stage I | 201 | 95.3 |
| Stage II & III | 10 | 4.7 |
| ART regimen | ||
| 1st line | 208 | 98.6 |
| 2nd line | 3 | 1.4 |
| Duration on ART | ||
| Between 1 & 6 months | 6 | 2.8 |
| > 6 months | 205 | 97.2 |
| CD4 count | ||
| < 200 cells/mm3 | 14 | 6.6 |
| ≥ 200 cells/mm3 | 197 | 93.4 |
| Mean = 559.5 (SD = 226.0) | ||
| Viral load | ||
| Undetected | 197 | 93.4 |
| Detected | 14 | 6.6 |
| ART adherence | ||
| Adherent | 132 | 62.6 |
| Non-adherent | 79 | 37.4 |
| ART non-adherence factors (n = 79) | ||
| Patient factors | 76 | 96.2 |
| Other factors | 3 | 3.8 |
aAnalyzed as a continuous variable